EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of CHI3L1 decreases N-cadherin and VCAM-1 levels in glioblastoma

Agnieszka Rusak, Marlena Gąsior-Głogowska iD, Azzurra Sargenti iD, Edward Krzyżak iD, Krzysztof Kotowski iD, Monika Mrozowska iD, Tomasz Górnicki iD, Krzysztof Kujawa iD, Piotr Dzięgiel iD

Pharmacological Reports · 2025

DOI: 10.1007/s43440-024-00677-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacological Reports, 2025. Verfasst von Agnieszka Rusak und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, T. Chałubińskiego 6a, Wroclaw, 50-36…. Hauptthemen laut MEDLINE: Glioblastoma, Cadherins, Chitinase-3-Like Protein 1, Vascular Cell Adhesion Molecule-1. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background The protein CHI3L1 contributes to cancer development by several mechanisms, including stimulation of angiogenesis and invasion as well as immunomodulatory effects. These properties make it a potential target for the development of targeted therapies in precision medicine. In this context, the particular potential of CHI3L1 inhibition could be considered in glioblastoma multiforme (GBM), whose tumors exhibit high levels of angiogenesis and increased CHI3L1 expression. This study aims to investigate whether inhibition of CHI3L1 in spheroids used as a GBM model affects the mechanisms of invasiveness; Methods We analyzed the interactions between CHI3L1 and the inhibitor G721-0282 in molecular docking and molecular dynamics (in silico) and infrared spectroscopy. Uptake of G721-0282 in GBM spheroids was measured using a label-free physical cytometer. Changes in E-, N- and VE-cadherins, VCAM-1, and EGFR were analyzed by immunohistochemical reactions, Western blot, and ddPCR methods in U-87 MG cells and GBM spheroids consisting of U-87 MG glioblastoma cells, HMEC-1 endothelial cells and macrophages; Results A direct interaction between CHI3L1 and G721-0282 was confirmed. G721-0282 decreased N-cadherins and VCAM-1 in GBM spheroids, but the changes in the 2D model of U-87 MG glioblastoma cells were different; Conclusion Inhibition of CHI3L1 has the potential to reduce the invasiveness of GBM tumors. The 3D model of GBM spheroids is of great significance for investigating changes in membrane proteins and the tumor microenvironment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaCadherinsChitinase-3-Like Protein 1Vascular Cell Adhesion Molecule-1Brain NeoplasmsHumansCell Line, TumorMolecular Docking SimulationSpheroids, Cellular

Stichwörter der Autor:innen

CHI3L1GlioblastomaN-cadherinPhysical cytometryVCAM-1

Substanzen

CadherinsChitinase-3-Like Protein 1CHI3L1 protein, humanVascular Cell Adhesion Molecule-1

Autor:innen und Institutionen

  • Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, T. Chałubińskiego 6a, Wroclaw, 50-368, Poland. agnieszka.rusak@umw.edu.pl.
  • Department of Biomedical Engineering, Faculty of Fundamental Problems of Technology, Wroclaw University of Science and Technology, 27, S. Wyspiańskiego, Wroclaw, 50-370, Poland.
  • CellDynamics Srl, Via Paolo Nanni Costa 20, Bologna, 40133, Italy.
  • Department of Basic Chemical Sciences, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211A, Wroclaw, 50-556, Poland.
  • Division of Histology and Embryology, Department of Human Morphology and Embryology, Wroclaw Medical University, T. Chałubińskiego 6a, Wroclaw, 50-368, Poland.
  • Statistical Analysis Centre, Wroclaw Medical University, K. Marcinkowskiego 2-6, Wroclaw, 50-368, Poland.

ORCID-Profile: Marlena Gąsior-Głogowska, Azzurra Sargenti, Edward Krzyżak, Krzysztof Kotowski, Monika Mrozowska, Tomasz Górnicki, Krzysztof Kujawa, Piotr Dzięgiel

Förderung

  • NIGMS NIH HHS
  • Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu

Zitieren

APA

Rusak, A., Gąsior-Głogowska, M., Sargenti, A., Krzyżak, E., Kotowski, K., Mrozowska, M., Górnicki, T., Kujawa, K., & Dzięgiel, P. (2025). Inhibition of CHI3L1 decreases N-cadherin and VCAM-1 levels in glioblastoma. Pharmacological Reports. https://doi.org/10.1007/s43440-024-00677-3

Vancouver

Rusak A, Gąsior-Głogowska M, Sargenti A, Krzyżak E, Kotowski K, Mrozowska M, et al. Inhibition of CHI3L1 decreases N-cadherin and VCAM-1 levels in glioblastoma. Pharmacological Reports. 2025. doi:10.1007/s43440-024-00677-3

BibTeX
@article{Rusak2025,
  author = {Rusak, Agnieszka and Gąsior-Głogowska, Marlena and Sargenti, Azzurra and Krzyżak, Edward and Kotowski, Krzysztof and Mrozowska, Monika and Górnicki, Tomasz and Kujawa, Krzysztof and Dzięgiel, Piotr},
  title = {Inhibition of CHI3L1 decreases N-cadherin and VCAM-1 levels in glioblastoma},
  journal = {Pharmacological Reports},
  year = {2025},
  doi = {10.1007/s43440-024-00677-3}
}
Kostenlos starten →